Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BioLargoBLGO +3.64% Days Payable is 211.40 as of Jun. 2026, which is 102% above its 10-year median of 104.82. The stock has 8 warning signs investors should review. Among 1,562 Chemicals companies, BioLargo ranks better than 93.92% on this metric.
BioLargo's average Accounts Payable for the
three
months ended in Jun. 2026 was $1.33 Mil. BioLargo's Cost of Goods Sold for the
three
months ended in Jun. 2026 was $0.57 Mil.
Hence, BioLargo's Days Payable for the
three
months ended in Jun. 2026 was 211.40.
The historical rank and industry rank for BioLargo's Days Payable or its related term are showing as below:
BLGO'
s Days Payable Range Over the Past 10 Years
Min: 44.49 Med: 104.82 Max: 339.17
Current: 206.66
During the past 13 years, BioLargo's highest Days Payable was 339.17. The lowest was 44.49. And the median was 104.82.
BLGO's Days Payable is ranked better than 93.92% of 1562
companies
in the Chemicals industry
Industry Median: 59.26
vs BLGO: 206.66
BioLargo's Days Payable
increased
from Jun. 2025 (103.87) to Jun. 2026 (211.40).
It may suggest that BioLargodelayed paying its suppliers.
The historical data trend for BioLargo's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, BioLargo's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioLargo Days Payable vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, BioLargo's Days Payable distribution charts can be found below:
* The bar in red indicates where BioLargo's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
BioLargo's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioLargo (BLGO) has a Days Payable of 211.40 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on BioLargo and its competitors. This is 102% above median its historical median of 104.82. Over the past decade, BioLargo's Days Payable has ranged from 44.49 to 339.17. According to the industry distribution chart, BioLargo ranks #95 out of 1562 companies in the Chemicals industry, placing it in the top 6.1%.
Is BioLargo's Days Payable too high?
BioLargo's current Days Payable of 211.40 is 102% above median its 10-year median of 104.82. Over the past 10 years, this metric has ranged from a low of 44.49 to a high of 339.17. The Chemicals industry median Days Payable is 59.26. BioLargo's value of 211.40 is 256.7% above this industry median. Based on the distribution chart, BioLargo ranks #95 out of 1562 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers.
How does BioLargo's Days Payable compare to BIOF and LOOP?
According to the Chemicals industry distribution chart, BioLargo ranks #95 out of 1562 companies for Days Payable. This places BioLargo in the top 6% of its industry — outperforming the majority of peers. The industry median Days Payable is 59.26. BioLargo's value of 211.40 is 256.7% above this benchmark. Historically, BioLargo's own Days Payable has ranged from 44.49 to 339.17 over the past decade. While the company's 10-year median is 104.82 vs. the industry median of 59.26, BioLargo has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Chemicals company?
The median Days Payable among Chemicals companies is 59.26, based on 1,562 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BioLargo's current Days Payable of 211.40 is 256.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on BioLargo and its competitors. For the Chemicals industry, the median Days Payable is 59.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioLargo's current Days Payable is 211.40, which is 102% above median its own 10-year median of 104.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioLargo stock overvalued right now?
Based on GuruFocus' analysis, BioLargo (BLGO) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.07, compared to a current price of $0.10 — trading 38.4% above its estimated fair value. The current Days Payable is 211.40, which is 102% above median its 10-year median of 104.82 and 256.7% above the Chemicals industry median of 59.26. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For BioLargo (BLGO), the current Days Payable is 211.40 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BioLargo Inc invents, develops, and commercializes platform technologies to solve challenging environmental problems like PFAS contamination, water and wastewater treatment, industrial odor, VOC control, air quality control, and infection control. The company has six segments: ONM Environmental; Clyra Medical; BLEST; BETI; BEST; and BioLargo Canada. ONM Environmental, which sells odor and volatile organic control products and services, located in Westminster, California, derives the maximum revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BLGO has been successfully added to your 
